Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases

Journal of Cellular Biochemistry

Volumn 88, Issue 2, 2003, Pages 227-233

  Adorini, Luciano ^a   Penna, Giuseppe ^a   Giarratana, Nadia ^a   Uskokovic, Milan ^b  

^a BioXell SpA   (Italy)

^b Bioxell Inc   (United States)

Author keywords

Immunoregulation; Regulatory T cells; Tolerance; Vitamin D analogues

Indexed keywords

1,25 DIHYDROXY 16,23 DIENE 26,27 HEXAFLUORO 19 NOR VITAMIN D3; AUTOANTIGEN; B7 ANTIGEN; BXL 698; CALCITRIOL; CALCITRIOL DERIVATIVE; CD4 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2 RECEPTOR; LIGAND; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CONFERENCE PAPER; CYTOKINE RELEASE; DENDRITIC CELL; DRUG POTENTIATION; EXPERIMENTAL MOUSE; GRAFT REJECTION; HEART GRAFT; HYPERCALCEMIA; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL;

ANIMALS; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; LIGANDS; MICE; MICE, INBRED NOD; RECEPTORS, CALCITRIOL; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; VITAMIN D;

EID: 0037302966     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10340     Document Type: Conference Paper

References (41)

1. Adorini L. 2001. Interleukin 12 and autoimmune diabetes. Nat Genet 27:131-132.
2. Allison AC, Eugui EM. 1996: Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin Transplant 10:77-84.
3. Alroy I, Towers T, Freedman L. 1995. Transcriptional repression of the interleukin-2 gene by vitamin D3: Direct inhibition NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 15:5789-5799.
4. Atkinson MA, Leiter EH. 1999. The NOD mouse model of type 1 diabetes: As good as it gets? Nat Med 5:601-604.
5. Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-Malefyt R, Coffman RL, Hawrylowicz CM, O'Garra A. 2002. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 195:603-616.
6. Benoist C, Mathis D. 1997. Cell death mediators in autoimmune diabetes - No shortage of suspects. Cell 89:1-3.
7. Berer A, Stockl J, Majdic O, Wagner T, Kollars M, Lechner K, Geissler K, Oehler L. 2000. 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol 28:575-583.
8. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O'Garra A. 2001. 1alpha,25-Dihydroxyvitamin D3 has a direct effect on naive CD4+ T cells to enhance the development of Th2 cells. J Immunol 167:4974-4980.
9. Canning MO, Grotenhuis K, de Wit H, Ruwhof C, Drexhage HA. 2001. 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol 145:351-357.
10. Casteels K, Waer M, Laureys J, Valckx D, Depovere J, Bouillon R, Mathieu C. 1998a. Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine. Transplantation 65: 1225-1232.
11. Casteels KM, Gysemans CA, Waer M, Bouillon R, Laureys JM, Depovere J, Mathieu C. 1998b. Sex difference in resistance to dexamethasone-induced apoptosis in NOD mice: Treatment with 1,25(OH)2D3 restores defect. Diabetes 47:1033-1037.
12. Chang TJ, Lei HH, Yeh JI, Chiu KC, Lee KC, Chen MC, Tai TY, Chuang LM. 2000. Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population. Clin Endocrinol 52:575-580.
13. Cippitelli M, Santoni A. 1998. Vitamin D3: A transcriptional modulator of the IFN-ygene. Eur J Immunol. 28: 3017-3030.
14. D'Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R, Sinigaglia F, Panina-Bordignon P. 1998. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 101: 252-262.
15. Delovitch TL, Singh B. 1997. The non-obese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD. Immunity 7:727-738.
16. Green A, Gale EA, Patterson CC. 1992. Incidence of childhood-onset insulin-dependent diabetes mellitus: The EURODIAB ACE Study. Lancet 339:905-909.
17. Gregori G, Giarratana N, Smiroldo S, Uskokovic M, Adorini L 2002: A 1α,25-Dihydroxyvitamin D3 analog enhances regulatory T cells and arrests autoimmune diabetes in NOD mice. Diabetes 51:1367-1374.
18. Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L 2001: Regulatory T cells induced by 1α,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 167:1945-1953.
19. Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R. 2001. Dendritic cell modulation by lalpha,25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 22:22.
20. Griffin MD, Lutz WH, Phan VA, Bachman LA, McKean DJ, Kumar R. 2000. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun 270:701-708.
21. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737-742.
22. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW. 1998. The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed. J Bone Miner Res 13:325-349.
23. Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH. 2000. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192:1213-1222.
24. Lemire JM, Archer DC, Beck L, Spiegelberg HL. 1995. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: Preferential inhibition of Th1 functions. J Nutr 125:1704S-1708S.
25. Mathieu C, Adorini L. 2002. The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med 8:174-179.
26. Mathieu C, Casteels K, Boullion R. 1997. Vitamin D and diabetes. In: Feldman D, Glorieux FH, Pike JW, editors. Vitamin D. San Diego: Academic Press.
27. Mathieu C, Laureys J, Sobis H, Vandeputte M, Waer M, Bouillon R. 1992. 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes 41:1491-1495.
28. Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R. 1994. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia 37:552-558.
29. Mattner F, Smiroldo S, Galbiati F, Muller M, Di Lucia P, Poliani PL, Martino G, Panina-Bordignon P, Adorini L. 2000. Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D3. Eur J Immunol 30:498-508.
30. Mehling A, Grabbe S, Voskort M, Schwarz T, Luger TA, Beissert S. 2000. Mycophenolate mofetil impairs the maturation and function of murine dendritic cells. J Immunol 165:2374-2381.
31. Norman AW, Ishizuka S, Okamura WH. 2001. Ligands for the vitamin D endocrine system: Different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein. J Steroid Biochem Mol Biol 76:49-59.
32. Pani MA, Knapp M, Donner H, Braun J, Baur MP, Usadel KH, Badenhoop K. 2000. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes 49:504-507.
33. Penna G, Adorini L. 2000. 1,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164:2405-2411.
34. Piemonti L, Monti P, Sironi M, Fraticelli P, Leone BE, Dal Cin E, Allavena P, Di Carlo V. 2000. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 164:4443-4451.
35. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1983. 1,25-Dihydroxyvitamin D3 receptors in human leukocytes. Science 221:1181-1183.
36. Ridgway WM, Fasso M, Lanctot A, Garvey C, Fathman CG. 1996. Breaking self-tolerance in nonobese diabetic mice. J Exp Med 183:1657-1662.
37. Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, Sharpe A, Bluestone JA. 2000. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431-440.
38. Takeuchi A, Reddy G, Kobayashi T, Okano T, Park J, Sharma S. 1998: Nuclear factor of activated T cells (NFAT) as a molecular target for 1α,25-dihydroxyvitamin D3-mediated effects. J Immunol 160:209-218.
39. The EURODIAB Substudy 2 Study Group. 1999. Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. Diabetologia 42: 51-54.
40. Trembleau S, Penna G, Bosi E, Mortara A, Gately MK, Adorini L. 1995. IL-12 administration induces Th1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 181:817-821.
41. Uskokovic MR, Norman AW, Manchand PS, Studzinski GP, Campbell MJ, Koeffler HP, Takeuchi A, Siu-Caldera M, Rao DS, Reddy GS. 2001. Highly active analogs of 1 alpha,25-dihydroxyvitamin D(3) that resist metabolism through C-24 oxidation and C-3 epimerization pathways. Steroids 66:463-471.